Clinical Trial Update: Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1 [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports a comparison of buprenorphine formulations (sublingual tablet vs. solution) for opioid-related disorders in Phase 1/2, sponso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Opioid-Related Disorders | Phase 1, Phase 2 | Status: COMPLETED